Topic

Virginia

A collection of 501 issues

How to Get Ilaris (Canakinumab) Covered by Aetna (CVS Health) in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Ilaris (Canakinumab) Covered by Aetna (CVS Health) in Virginia Aetna (CVS Health) requires strict prior authorization for Ilaris (canakinumab) in Virginia, covering only FDA-approved conditions like Still's disease, periodic fever syndromes (CAPS, TRAPS, HIDS/MKD, FMF), with specialist prescribing and documented treatment failures. Fastest path
5 min read

How to Get Skyrizi (Risankizumab) Covered by UnitedHealthcare in Virginia: Complete Guide to Prior Authorization, Appeals, and State Protections

Answer Box: Getting Skyrizi Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Skyrizi (risankizumab) in Virginia with mandatory step therapy—you must try and fail at least one TNF inhibitor first. Submit your PA request through the UHC Provider Portal or call OptumRx at 1-800-711-4555. Include documentation of
6 min read

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by UnitedHealthcare in Virginia: Prior Authorization, Appeals & Forms

Quick Answer: Getting Lutathera Covered by UnitedHealthcare in Virginia Lutathera requires prior authorization from UnitedHealthcare OptumRx in Virginia. Your oncologist must submit clinical documentation proving somatostatin receptor positivity, appropriate tumor grading, and progression on octreotide/lanreotide. If denied, you have 180 days for internal appeals, then 120 days to file
5 min read

How to Get Alprolix (eftrenonacog alfa) Covered by Cigna in Virginia: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Alprolix Covered by Cigna in Virginia Cigna requires prior authorization for Alprolix (eftrenonacog alfa) with step therapy requirements. Your fastest path to approval: (1) Have your hematologist submit a prior authorization request through CoverMyMeds or Cigna's provider portal documenting hemophilia B diagnosis, failed preferred factor
5 min read